Profile: Shima Laboratories Co., Ltd. focuses on fibrinogen & fibrin split products, immunoreactive insulin radioimmunoassay tests and secondary calibrators.
FDA Registration Number: 3003985394
US Agent: Colin Getty / Kamiya Biomedical Company
Phone: +1-(206)-575-8068 Fax: +1-(206)-575-8094 E-Mail:
5 Products/Services (Click for related suppliers)
|
• Fibrin Split Products (FDA Code: GHH / 864.7320) A fibrinogen/fibrin degradation products assay is a device used to detect and measure fibrinogen degradation products and fibrin degradation products (protein fragments produced by the enzymatic action of plasmin on fibrinogen and fibrin) as an aid in detecting the presence and degree of intravascular coagulation and fibrinolysis (the dissolution of the fibrin in a blood clot) and in monitoring therapy for disseminated intravascular coagulation (nonlocalized clotting in the blood vessels). |
• Fibrinogen and Fibrin Split Products (FDA Code: DAP / 864.7320) |
• IgE Control (FDA Code: DGC / 866.5510) An immunoglobulins A, G, M, D, and E immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the immunoglobulins A, G, M, D, an E (serum antibodies) in serum. Measurement of these immunoglobulins aids in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents. |
• Immunoreactive Insulin Radioimmunoassay Test (FDA Code: CFP / 862.1405) An immunoreactive insulin test system is a device intended to measure immunoreactive insulin in serum and plasma. Immunoreactive insulin measurements are used in the diagnosis and treatment of various carbohydrate metabolism disorders, including diabetes mellitus, and hypoglycemia. |
• Secondary Calibrator (FDA Code: JIT / 862.1150) A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also 862.2 in this part.) |